[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Motexafin Lutetium (CAS 42924-53-8) Market Research Report 2024

April 2024 | 50 pages | ID: MA6149707FEEN
BAC Reports

US$ 2,200.00 US$ 2,650.00 -17 %
Offer valid until April 30, 2024!

Email Delivery - PDF (on default)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question

Motexafin Lutetium (CAS 42924-53-8) Market Research Report 2024 presents comprehensive data on Motexafin Lutetium markets globally and regionally (Europe, Asia, North America etc.)

The report includes Motexafin Lutetium description, covers its application areas and related patterns. It overviews Motexafin Lutetium market, names Motexafin Lutetium producers and indicates its suppliers.

Besides, the report provides Motexafin Lutetium prices in regional markets.

In addition to the above the report determines Motexafin Lutetium consumers in the market.

BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).

We can analyze the following elements for each chemical product in any country or region:

  • capacities and production
  • consumption volume and structure
  • market price trends
  • exports and imports
  • existing technologies
  • feedstock market condition
  • market news digest
  • market forecast.

Motexafin Lutetium (CAS 42924-53-8) Market Research Report 2024 can feature:

  • market condition and estimations, market forecast
  • chemical product ranges, trademarks, analogous products, application areas
  • regional and global producers, consumers and traders (including contact details).

1. MOTEXAFIN LUTETIUM (CAS 42924-53-8)

1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. MOTEXAFIN LUTETIUM APPLICATIONS

2.1. Motexafin Lutetium application spheres, downstream products

3. MOTEXAFIN LUTETIUM MANUFACTURING METHODS

4. MOTEXAFIN LUTETIUM PATENTS

Abstract
Description
Summary of the invention
Detailed description of the invention

5. MOTEXAFIN LUTETIUM MARKET WORLDWIDE 

5.1. General Motexafin Lutetium market situation, trends
5.2. Manufacturers of Motexafin Lutetium
- Europe
- Asia
- North America
- Other regions
5.3. Motexafin Lutetium suppliers (importers, local distributors)
- Europe
- Asia
- North America
- Other regions
5.4. Motexafin Lutetium market forecast

6. MOTEXAFIN LUTETIUM MARKET PRICES

6.1. Motexafin Lutetium prices in Europe
6.2. Motexafin Lutetium prices in Asia
6.3. Motexafin Lutetium prices in North America
6.4. Motexafin Lutetium prices in other regions

7. MOTEXAFIN LUTETIUM END-USE SECTOR 

7.1. Motexafin Lutetium market by application sphere
7.2. Motexafin Lutetium downstream markets trends and prospects

*Please note that Motexafin Lutetium (CAS 42924-53-8) Market Research Report 2024 is a half ready publication and contents are subject to change. It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 5-7 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 25,000 different chemicals available but it is impossible to have all reports updated immediately. That is why it takes 5-7 days to update a report after an order is received.

Product Name:Motexafin Lutetium
Synonyms:
  • Nabumetone
  • 2-Butanone, 4-(6-methoxy-2-naphthalenyl)-
  • 4-(6-Methoxy-2-naphthalenyl)-2-butanone
  • 4-(6-Methoxy-2-naphthyl)-2-butanone
  • 4-(6-Methoxynaphthalen-2-yl)butan-2-one
  • BRL-147777
  • NABUMETONE
  • Motexafin Lutetium
CAS#:42924-53-8
Formula:C15H16O2
Molecular Weight:228.29
Usage:Used to treat pain or inflammation caused by arthritis.



More Publications